ARROW SUPER ARROW FLEX 7 FR INTRODUCER SHEATH
Report
- Report Number
- 3012279212-2020-00002
- Event Type
- Injury
- Date Received
- March 27, 2020
- Date of Event
- February 27, 2020
- Report Date
- March 27, 2020
- Manufacturer
- TELEFLEX
- Product Code
- DYB
- PMA / PMN Number
- K970229
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- PHYSICIAN
Narratives
PRYTIME IS REPORTING THIS MDR BECAUSE IT PROVIDES A CONVENIENCE KIT WITH A 7 FR INTRODUCER SHEATH TO THE USER FACILITY. PRYTIME MEDICAL IS LISTED AS THE LEGAL MANUFACTURER OF THE CONVENIENCE KIT BY VIRTUE OF ITS ROLE AS A REPACKAGER. THE ITEMS WITHIN THE KIT ARE SUPPLIED IN THEIR ORIGINAL SEALED OEM PACKAGING. THE 7 FR INTRODUCER SHEATH INCLUDED IN THIS CONVENIENCE KIT IS MANUFACTURED BY TELEFLEX, INC. IT IS UNKNOWN IF THIS SHEATH WAS USED IN THIS CASE . THE REPORTING PHYSICIAN, DR. (B)(6) COMMUNICATED THAT UAMS HAS PERFORMED APPROXIMATELY 18 REBOA PROCEDURES IN HIGH-RISK OBSTETRICS PATIENTS PRIOR TO 2020 WITHOUT EXPERIENCING ISSUES. SINCE THE START OF THE YEAR, THEY HAVE PERFORMED 3 REBOA PROCEDURES, 2 OF WHICH THEY EXPERIENCED COMPLICATIONS RELATED TO THE INTRODUCER SHEATH. TWO NOTABLE DIFFERENCES ASSOCIATED WITH THE CASES PERFORMED IN 2020 ARE DR. (B)(6), THE TRAUMA SURGEON WHO WAS PREVIOUSLY CALLED UPON TO PHYSICALLY DEPLOY THE ER-REBOA CATHETER IN HIGH-RISK OBSTETRICS PATIENTS IS NO LONGER WORKING AT UAMS. THE PRACTICE FOR HIGH-RISK OBSTETRICS PATIENTS AT UAMS HAS SHIFTED FROM PROPHYLACTIC DEPLOYMENT OF THE ER-REBOA CATHETER TO PROPHYLACTIC DEPLOYMENT OF A 5 FR. MICRO CATHETER, WHICH WOULD BE UPSIZED TO A 7 FR. INTRODUCER SHEATH TO DEPLOY THE ER-REBOA CATHETER IF NECESSARY. IN RESPONSE TO THE ISSUES EXPERIENCED, DR. (B)(6) REPORTED THAT UAMS IS REVERTING TO THE PRACTICE OF PROPHYLACTIC DEPLOYMENT OF THE ER-REBOA CATHETER INSTEAD OF THE 5 FR. MICRO CATHETER FOR HIGH-RISK OBSTETRICS PATIENTS. PRYTIME IS ALSO WORKING WITH UAMS TO SCHEDULE ADDITIONAL ON-SITE TRAINING.
A 5 FR MICRO CATHETER WAS PLACED PROPHYLACTICALLY IN THE CFA OF AN OBSTETRIC PATIENT KNOWN TO BE AT HIGH-RISK OF HEMORRHAGE. THE PATIENT BECAME HYPOTENSIVE AND THE DECISION WAS MADE TO UPSIZE TO A 7 FR INTRODUCER AND PLACE THE ER-REBOA CATHETER EMERGENTLY TO CONTROL HEMORRHAGE. THE BALLOON WAS INFLATED AND HEMORRHAGE CONTROL ACHIEVED. AT SOME POINT DURING THE PROCEDURE A VESSEL DISSECTION WAS DETECTED. WHEN THE ISSUE WAS REPORTED TO PRYTIME MEDICAL, THE REPORTING PHYSICIAN WAS CLEAR THAT THEY BELIEVED THE DISSECTION TO BE RELATED TO USE OF THE 7 FR INTRODUCER SHEATH, SPECIFICALLY WHEN UPSIZING FROM THE 5 FR MICRO CATHETER, AND NOT RELATED TO USE OF ER-REBOA CATHETER WHICH FUNCTIONED AS INTENDED. ULTIMATELY THE PATIENT SURVIVED. OTHER FACTS AND DETAILS OF THE CASE ARE UNKNOWN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 354665 | ARROW SUPER ARROW FLEX 7 FR INTRODUCER SHEATH | INTRODUCER, CATHETER | DYB | TELEFLEX | CP-07711 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |